Ardelyx (ARDX) Accounts Payables (2013 - 2026)
Ardelyx (ARDX) reported Accounts Payables of $28.2 million for Q1 2026, up 105.47% on a YoY basis from $13.7 million in Q1 2025, and up 46.58% quarter-over-quarter from $19.2 million in Q4 2025.
Ardelyx (ARDX) Accounts Payables (2013 - 2026) Analysis & Trends
Ardelyx has reported Accounts Payables for 14 years, with the latest figure at $28.2 million in Q1 2026.
- For the quarter ending Q1 2026, Accounts Payables rose 105.47% year-over-year to $28.2 million; the trailing twelve-month figure through Mar 2026 stood at $28.2 million (up 105.47% YoY), and the FY2025 full-year result was $19.2 million, up 20.22% from the prior year.
- Accounts Payables for Q1 2026 stood at $28.2 million, up from $19.2 million in the prior quarter.
- The five-year high for Accounts Payables was $28.2 million in Q1 2026, with the low at $3.1 million in Q3 2022.
- Historically, Accounts Payables has averaged $12.9 million across 5 years, with a median of $11.1 million in 2023.
- The largest YoY upside for Accounts Payables was 153.89% in 2022 against a maximum downside of 26.98% in 2022.
- Ardelyx's Accounts Payables stood at $10.9 million in 2022, then climbed by 2.57% to $11.1 million in 2023, then soared by 43.65% to $16.0 million in 2024, then grew by 20.22% to $19.2 million in 2025, then soared by 46.58% to $28.2 million in 2026.
- The last three Accounts Payables figures came in at $28.2 million (Q1 2026), $19.2 million (Q4 2025), and $18.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 8.64 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 34.55 Mn |
| 10 | Ardelyx | 1.49 Bn | 1.25 Bn | 89.66 Mn | 28.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.20 Mn |
| Dec 31, 2025 | 19.24 Mn |
| Sep 30, 2025 | 18.39 Mn |
| Jun 30, 2025 | 21.69 Mn |
| Mar 31, 2025 | 13.72 Mn |
| Dec 31, 2024 | 16.00 Mn |
| Sep 30, 2024 | 15.82 Mn |
| Jun 30, 2024 | 10.88 Mn |
| Mar 31, 2024 | 17.28 Mn |
| Dec 31, 2023 | 11.14 Mn |
| Sep 30, 2023 | 7.74 Mn |
| Jun 30, 2023 | 5.29 Mn |
| Mar 31, 2023 | 10.51 Mn |
| Dec 31, 2022 | 10.86 Mn |
| Sep 30, 2022 | 3.11 Mn |
| Jun 30, 2022 | 4.29 Mn |
| Mar 31, 2022 | 5.03 Mn |
| Dec 31, 2021 | 4.28 Mn |
| Sep 30, 2021 | 4.26 Mn |
| Jun 30, 2021 | 2.59 Mn |